These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 33928224)

  • 1. Effect of allotypic variation of human IgG1 on the thermal stability of disulfide-linked knobs-into-holes mutants of the Fc for stable bispecific antibody design.
    Akiba H; Satoh R; Nagata S; Tsumoto K
    Antib Ther; 2019 Jul; 2(3):65-69. PubMed ID: 33928224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural differences between glycosylated, disulfide-linked heterodimeric Knob-into-Hole Fc fragment and its homodimeric Knob-Knob and Hole-Hole side products.
    Kuglstatter A; Stihle M; Neumann C; Müller C; Schaefer W; Klein C; Benz J;
    Protein Eng Des Sel; 2017 Sep; 30(9):649-656. PubMed ID: 28985438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single mutation increases heavy-chain heterodimer assembly of bispecific antibodies by inducing structural disorder in one homodimer species.
    Stutz C; Blein S
    J Biol Chem; 2020 Jul; 295(28):9392-9408. PubMed ID: 32404368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiparallel conformation of knob and hole aglycosylated half-antibody homodimers is mediated by a CH2-CH3 hydrophobic interaction.
    Elliott JM; Ultsch M; Lee J; Tong R; Takeda K; Spiess C; Eigenbrot C; Scheer JM
    J Mol Biol; 2014 May; 426(9):1947-57. PubMed ID: 24576605
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Knobs-into-holes' engineering of antibody CH3 domains for heavy chain heterodimerization.
    Ridgway JB; Presta LG; Carter P
    Protein Eng; 1996 Jul; 9(7):617-21. PubMed ID: 8844834
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knobs-into-holes antibody production in mammalian cell lines reveals that asymmetric afucosylation is sufficient for full antibody-dependent cellular cytotoxicity.
    Shatz W; Chung S; Li B; Marshall B; Tejada M; Phung W; Sandoval W; Kelley RF; Scheer JM
    MAbs; 2013; 5(6):872-81. PubMed ID: 23995614
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production of bispecific antibodies in "knobs-into-holes" using a cell-free expression system.
    Xu Y; Lee J; Tran C; Heibeck TH; Wang WD; Yang J; Stafford RL; Steiner AR; Sato AK; Hallam TJ; Yin G
    MAbs; 2015; 7(1):231-42. PubMed ID: 25427258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural basis of a novel heterodimeric Fc for bispecific antibody production.
    Wei H; Cai H; Jin Y; Wang P; Zhang Q; Lin Y; Wang W; Cheng J; Zeng N; Xu T; Zhou A
    Oncotarget; 2017 Aug; 8(31):51037-51049. PubMed ID: 28881627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bispecific antibody process development: Assembly and purification of knob and hole bispecific antibodies.
    Giese G; Williams A; Rodriguez M; Persson J
    Biotechnol Prog; 2018 Mar; 34(2):397-404. PubMed ID: 29193902
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoglobulin Fc Heterodimer Platform Technology: From Design to Applications in Therapeutic Antibodies and Proteins.
    Ha JH; Kim JE; Kim YS
    Front Immunol; 2016; 7():394. PubMed ID: 27766096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization and Monitoring of a Novel Light-heavy-light Chain Mispair in a Therapeutic Bispecific Antibody.
    Cao M; Parthemore C; Jiao Y; Korman S; Aspelund M; Hunter A; Kilby G; Chen X
    J Pharm Sci; 2021 Aug; 110(8):2904-2915. PubMed ID: 33894207
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stabilisation of the Fc fragment of human IgG1 by engineered intradomain disulfide bonds.
    Wozniak-Knopp G; Stadlmann J; Rüker F
    PLoS One; 2012; 7(1):e30083. PubMed ID: 22272277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improving target cell specificity using a novel monovalent bispecific IgG design.
    Mazor Y; Oganesyan V; Yang C; Hansen A; Wang J; Liu H; Sachsenmeier K; Carlson M; Gadre DV; Borrok MJ; Yu XQ; Dall'Acqua W; Wu H; Chowdhury PS
    MAbs; 2015; 7(2):377-89. PubMed ID: 25621507
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crystal structures of immunoglobulin Fc heterodimers reveal the molecular basis for heterodimer formation.
    Choi HJ; Seok SH; Kim YJ; Seo MD; Kim YS
    Mol Immunol; 2015 Jun; 65(2):377-83. PubMed ID: 25743157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design Principles for Bispecific IgGs, Opportunities and Pitfalls of Artificial Disulfide Bonds.
    Vaks L; Litvak-Greenfeld D; Dror S; Shefet-Carasso L; Matatov G; Nahary L; Shapira S; Hakim R; Alroy I; Benhar I
    Antibodies (Basel); 2018 Jul; 7(3):. PubMed ID: 31544879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Removal of a C-terminal serine residue proximal to the inter-chain disulfide bond of a human IgG1 lambda light chain mediates enhanced antibody stability and antibody dependent cell-mediated cytotoxicity.
    Shen Y; Zeng L; Zhu A; Blanc T; Patel D; Pennello A; Bari A; Ng S; Persaud K; Kang YK; Balderes P; Surguladze D; Hindi S; Zhou Q; Ludwig DL; Snavely M
    MAbs; 2013; 5(3):418-31. PubMed ID: 23567210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive elucidation of the structural and functional roles of engineered disulfide bonds in antibody Fc fragment.
    Zeng F; Yang C; Gao X; Li X; Zhang Z; Gong R
    J Biol Chem; 2018 Dec; 293(49):19127-19135. PubMed ID: 30327432
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel efficient bispecific antibody format, combining a conventional antigen-binding fragment with a single domain antibody, avoids potential heavy-light chain mis-pairing.
    Huang S; Segués A; Hulsik DL; Zaiss DM; Sijts AJAM; van Duijnhoven SMJ; van Elsas A
    J Immunol Methods; 2020 Aug; 483():112811. PubMed ID: 32569598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disulfide Modified IgG1: An Investigation of Biophysical Profile and Clinically Relevant Fc Interactions.
    Bahou C; Love EA; Leonard S; Spears RJ; Maruani A; Armour K; Baker JR; Chudasama V
    Bioconjug Chem; 2019 Apr; 30(4):1048-1054. PubMed ID: 30855134
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human G1m1 allotype associates with CD4+ T-cell responsiveness to a highly conserved IgG1 constant region peptide and confers an asparaginyl endopeptidase cleavage site.
    Stickler MM; Reddy A; Xiong JM; Hinton PR; DuBridge R; Harding FA
    Genes Immun; 2011 Apr; 12(3):213-21. PubMed ID: 21326320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.